Researchers target the Achilles' heel of bacteria behind hospital-associated infections

July 17, 2013, Kansas State University

Kansas State University researchers are defeating persistent bacteria known for causing infections in hospitals.

The , Enterococcus faecalis, are the second-leading cause of hospital-associated infections in the U.S., said Lynn Hancock, associate professor of biology and leader of the research. His team has discovered how a regulatory system helps this bacteria resist a host's innate immune defense—a finding that may help develop novel drug compounds to fight the bacteria.

"Right now, we have very limited therapeutic interventions because the bacteria is highly resistant to not only antibiotics but a variety of other ," Hancock said. "With the diminishing number of antibiotics that are effective at treating these types of infections, we need to come up with new strategies."

Enterococcus faecalis, or E. faecalis, is naturally found in the of humans and other mammals. But outside the intestinal walls, the bacteria can cause bacteremia, and endocarditis.

An added obstacle is that the bacteria are 100 to 1,000 times more resistant to lysozyme than other bacteria, Hancock said. Lysozyme is an infection-fighting substance that humans produce and is found in numerous body tissues, such as tear film, the urinary tract and saliva. The regulatory system of E. faecalis also makes it very resistant to other cellular stresses—such as elevated temperature, low pH and —that are part of a person's innate and help .

"Enterococcus has evolved sensing systems to find out the kind of environment it is in," said Sriram Varahan, doctoral student in microbiology and member of Hancock's research team. "It is a really rugged bacteria that is known to persist and survive in environments where other pathogens are unable to do so. Many infectious disease specialists have given it the moniker of being the of the ."

By understanding the bacteria's regulatory network, the researchers hope to develop novel that can block the bacterium's ability to sense and respond to the presence of lysozyme and other stresses during infection. To find the bacteria's weakness, the scientists focused on a protein called Eep. While studies have shown that Eep is important during infection, the Kansas State University researchers discovered how Eep contributes to an important stress response that the bacteria use to survive the host defense.

It is an important finding because now researchers can develop compounds that inhibit the Eep protein, which makes the bacteria susceptible to lysozyme and stops infection. When humans produce lysozyme to fight the bacteria, the bacteria will be unable to fight back.

"It's kind of like hitting it in the Achilles' heel," Hancock said. "Then it is very much compromised to establish infection."

While the bacteria are still able to live without the Eep protein, the bacteria need it to cause infection, Hancock said. Studies have shown that when the Eep is inactivated, bacteria are compromised nearly 10,000-fold in their ability to cause infection.

"The ability to interfere with a bacteria's ability to establish infection is going to become a more popular theme for treating infections rather than simply killing the bacteria," Hancock said. "When you put selective pressure on bacterial populations to live or die, they are really good at circumventing the drugs and getting around the killing mechanism."

For future research, Hancock and his team want to find what compounds are most effective at interfering with Eep to make the bacteria susceptible to lysozyme. They also want to study the SigV protein, which coordinates expression of target genes that are controlled by the Eep protein. Similar to Eep, if SigV is inactivated, then the target genes are not expressed and the bacteria do not become resistant to lysozyme. These and proteins may also lead to new drug development possibilities.

"In the dawn of the post-antibiotic era, I think it is essential for us to have more options, rather than depending on a few silver bullets that are seemingly failing a lot in hospitals nowadays," Varahan said. "We have come up with new targets and hopefully they will work."

Explore further: Resistance to last-line antibiotic makes bacteria resistant to immune system

Related Stories

Resistance to last-line antibiotic makes bacteria resistant to immune system

May 21, 2013
Bacteria resistant to the antibiotic colistin are also commonly resistant to antimicrobial substances made by the human body, according to a study in mBio, the online open-access journal of the American Society for Microbiology. ...

Estrogen a new weapon against urinary tract infection in menopause

June 20, 2013
(Medical Xpress)—Estrogen stimulates the production of the body's own antibiotic and strengthens the cells in the urinary tract, according to a new study from Karolinska Institutet. The results, which are published in the ...

A shot in the arm for old antibiotics: Silver boosts antibiotics

June 19, 2013
Slipping bacteria some silver could give old antibiotics new life, scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University reported June 19 in Science Translational Medicine.

Recommended for you

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

Scientists unleash power of genetic data to identify disease risk

January 16, 2018
Massive banks of genetic information are being harnessed to shed new light on modifiable health risks that underlie common diseases.

Blood-vessel-on-a-chip provides insight into new anti-inflammatory drug candidate

January 15, 2018
One of the most important and fraught processes in the human body is inflammation. Inflammatory responses to injury or disease are crucial for recruiting the immune system to help the body heal, but inflammation can also ...

Molecule produced by fat cells reduces obesity and diabetes in mice

January 15, 2018
UC San Francisco researchers have discovered a new biological pathway in fat cells that could explain why some people with obesity are at high risk for metabolic diseases such as type 2 diabetes. The new findings—demonstrated ...

Obese fat becomes inflamed and scarred, which may make weight loss harder

January 12, 2018
The fat of obese people becomes distressed, scarred and inflamed, which can make weight loss more difficult, research at the University of Exeter has found.

Optimized human peptide found to be an effective antibacterial agent

January 11, 2018
A team of researchers in the Netherlands has developed an effective antibacterial ointment based on an optimized human peptide. In their paper published in the journal Science Translational Medicine, the group describes developing ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.